SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-023584
Filing Date
2022-05-03
Accepted
2022-05-03 16:01:51
Documents
35
Period of Report
2022-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159290-8k_lantern.htm   iXBRL 8-K 29312
2 PRESS RELEASE DATED MAY 3, 2022 ANNOUNCING FINANCIAL RESULTS FOR QUARTER ENDED M ea159290ex99-1_lantern.htm EX-99.1 45759
3 PRESENTATION RELATING TO MAY 3, 2022 CONFERENCE CALL AND LIVE WEBINAR TO DISCUSS ea159290ex99-2_lantern.htm EX-99.2 33082
7 GRAPHIC ex99-1_001.jpg GRAPHIC 3340
8 GRAPHIC ex99-2_001.jpg GRAPHIC 77530
9 GRAPHIC ex99-2_002.jpg GRAPHIC 337792
10 GRAPHIC ex99-2_003.jpg GRAPHIC 89224
11 GRAPHIC ex99-2_004.jpg GRAPHIC 120031
12 GRAPHIC ex99-2_005.jpg GRAPHIC 151189
13 GRAPHIC ex99-2_006.jpg GRAPHIC 155532
14 GRAPHIC ex99-2_007.jpg GRAPHIC 136960
15 GRAPHIC ex99-2_008.jpg GRAPHIC 173457
16 GRAPHIC ex99-2_009.jpg GRAPHIC 127725
17 GRAPHIC ex99-2_010.jpg GRAPHIC 134888
18 GRAPHIC ex99-2_011.jpg GRAPHIC 187832
19 GRAPHIC ex99-2_012.jpg GRAPHIC 136921
20 GRAPHIC ex99-2_013.jpg GRAPHIC 174401
21 GRAPHIC ex99-2_014.jpg GRAPHIC 154790
22 GRAPHIC ex99-2_015.jpg GRAPHIC 146402
23 GRAPHIC ex99-2_016.jpg GRAPHIC 110392
24 GRAPHIC ex99-2_017.jpg GRAPHIC 108525
25 GRAPHIC ex99-2_018.jpg GRAPHIC 114919
26 GRAPHIC ex99-2_019.jpg GRAPHIC 133402
27 GRAPHIC ex99-2_020.jpg GRAPHIC 53448
  Complete submission text file 0001213900-22-023584.txt   4205376

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ltrn-20220503.xsd EX-101.SCH 3048
5 XBRL LABEL FILE ltrn-20220503_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE ltrn-20220503_pre.xml EX-101.PRE 22605
29 EXTRACTED XBRL INSTANCE DOCUMENT ea159290-8k_lantern_htm.xml XML 3701
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 22886714
SIC: 2834 Pharmaceutical Preparations